脂联素与代谢综合征的研究进展

www.yongyao.net　　2009-8-31 11:58:06　　来源：　　责任编辑：

分享到：

[ 参考文献]
[ 1 ] 　Kralisch S, Sommer G,Deckert CM, et al. Adipokines in diabetes and cardiovascular diseases[ J ]. Minerva Endocrinol, 2007, 32 (3) : 1612171.
[ 2 ] 　Wassink AM, Olijhoek JK, Visseren FL. The metabolic syndrome: metabolic changeswith vascular consequences[ J ]. Eur J Clin Invest, 2007, 37 (1) : 8217.
[ 3 ] 　NedvídkováJ , Smitka K, Kop sk?V, et al. Adiponectin: an adipocyte2derived p rotein[ J ]. Physiol Res, 2005, 54 (2) : 1332140.
[ 4 ] 　Matsuzawa Y, Funahashi T,Nakamura T. Molecularmechanism ofmetabolic syndrome X: contribution of adipocytokines adipocyte2derived bioactive substances[ J ]. Ann NY Acad Sci, 1999, 892 (10) : 1462154.
[ 5 ] 　Díez JJ , Iglesias P. The role of the novel adipocyte2derived hormone adiponectin in human disease[ J ]. Eur J Endocrinol, 2003, 148 (3) : 2932300.
[ 6 ] 　Vasseur F, Lep rêtre F, Lacquemant C, et al. The genetics of adiponectin [ J ].CurrDiab Rep, 2003, 3 (2) : 1512158.
[ 7 ] 　Yamauchi T, Kamon J , Ito Y, et al. Cloning of adiponectin recep tors thatmediate antidiabetic effects[ J ]. Nature, 2003, 423 (6941) : 7622769.
[ 8 ] 　Wang Y, Xu A, Knight C, et al. Hydroxylation and glycosylation of the four conserved lysine residues in collagenous domain of adiponectin. Potential role in the modulation of its insulin2sensitizing activity[ J ]. J B iol Chem, 2002, 277 ( 22) :34658234661.
[ 9 ] 　MatsudaM, Shimomura I. Adipocytokines and metabolic syndrome2molecular mechanism and clinical imp lication[ J ]. Nippon Rinsho, 2004, 62 (6) : 108521090.
[ 10 ] 　Matsuzawa Y, Funahashi T, Kihara S, et al. Adiponectin and metabolic syndrome[ J ]. Arterioscler Thromb Vasc B iol, 2004, 24 (1) : 29238.
[ 11 ] 　Staiger H, Haring HU. Adipocytokines: fat2derived humoral mediators of metabolic homeostasis[ J ]. Exp Clin EndocrinolDiabetes, 2005, 113 (2) : 67279.
[ 12 ] 　Chan DC,Watts GF, Ng TW, et al. Adiponectin and other adipocytokines asp redictors of triglyceride2rich lipop rotein metabolism [ J ]. Clin Chem, 2005, 51(3) : 5782585.
[ 13 ] 　Maeda N, Shimomura I, Kishida K, et al. D iet2induced insulin resistance in mice lacking adiponectin /ACRP30 [ J ]. NatMed, 2002, 8 (7) : 7312737.
[ 14 ] 　L ihn AS, astergard T,Nyholm B, et al. Adiponectin mRNA exp ression in subcutaneous adipose tissue is reduced in first2degree relatives of type 2 diabetic patients[ J ]. Am J Physiol EndocrinolMetab, 2003, 284 (2) : E4432E448.
[ 15 ] 　Funahashi T, Nakamura T, Shimomura I, et al. Role of adipocytokines on the pathogenesis in visceral obesity[ J ]. InternMed, 1999, 38 (2) : 2022206.
[ 16 ] 　LechleitnerM, Koch T, Herold M, et al. Tumour necrosis factor2alpha p lasma level in patientswith type 1 diabetesmellitus and its association with glycaemic control and cardiovascular risk factors[ J ]. J InternMed, 2000, 248 (1) : 67276.
[ 17 ] 　Sudoh N, Toba K,AkishitaM, et al. Estrogen p revents oxidative stress2induced endothelial cell apop tosis in rats [ J ]. Circulation, 2001, 103 (5) : 7242729.
[ 18 ] 　AkishitaM, IwaiM,Wu L, et al. Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice [ J ]. Circulation, 2000, 102 (14) : 168421689.